STERIS Past Earnings Performance
Past criteria checks 2/6
STERIS's earnings have been declining at an average annual rate of -6.3%, while the Medical Equipment industry saw earnings growing at 13.5% annually. Revenues have been growing at an average rate of 15.7% per year. STERIS's return on equity is 8.8%, and it has net margins of 10.5%.
Key information
-6.3%
Earnings growth rate
-10.4%
EPS growth rate
| Medical Equipment Industry Growth | 8.9% |
| Revenue growth rate | 15.7% |
| Return on equity | 8.8% |
| Net Margin | 10.5% |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
Steris: Moving On, Losing Its Teeth
Apr 14STERIS plc's (NYSE:STE) Intrinsic Value Is Potentially 31% Above Its Share Price
Mar 29
STERIS (NYSE:STE) Has A Pretty Healthy Balance Sheet
Mar 07Steris: Strong Healthcare Products Growth Coupled With Weak AST Business
Feb 17STERIS plc's (NYSE:STE) Business Is Trailing The Industry But Its Shares Aren't
Feb 15An Intrinsic Calculation For STERIS plc (NYSE:STE) Suggests It's 23% Undervalued
Dec 17Should You Investigate STERIS plc (NYSE:STE) At US$203?
Nov 24Steris: Comprehensive Sterilization Portfolios Tailored To Procedure Volumes
Nov 08We Think STERIS (NYSE:STE) Can Stay On Top Of Its Debt
Nov 06Are STERIS plc (NYSE:STE) Investors Paying Above The Intrinsic Value?
Sep 18Steris: Remains On Track For Strong Fiscal '24, Added Upsides From Operating Leverage
Sep 01When Should You Buy STERIS plc (NYSE:STE)?
Aug 10Steris: Continuing To Grow The Product Lineup
Jun 20Steris falls 10% on Q3 revenue, profit miss, 2023 profit guidance lowered
Feb 09Steris declares $0.47 dividend
Feb 01These 4 Measures Indicate That STERIS (NYSE:STE) Is Using Debt Reasonably Well
Feb 01Calculating The Intrinsic Value Of STERIS plc (NYSE:STE)
Dec 28Steris declares $0.47 dividend
Nov 02STERIS (NYSE:STE) Seems To Use Debt Quite Sensibly
Nov 01Steris: Non-GAAP Valuations Supportive Of Substantial Upside
Sep 04STERIS (NYSE:STE) Will Pay A Larger Dividend Than Last Year At $0.47
Aug 18STERIS' (NYSE:STE) Dividend Will Be Increased To $0.47
Aug 04Steris Non-GAAP EPS of $1.90 in-line, revenue of $1.2B misses by $20M
Aug 02Is STERIS (NYSE:STE) A Risky Investment?
Jul 19Steris: Deleveraging Key Undercurrent, Valuation A Concern
Jun 12STERIS (NYSE:STE) Seems To Use Debt Quite Sensibly
Apr 08Steris: Another Essential Healthcare Supply Resource
Feb 01Is STERIS (NYSE:STE) A Risky Investment?
Dec 15STERIS (NYSE:STE) Is Increasing Its Dividend To US$0.43
Nov 01Revenue & Expenses BreakdownBeta
How STERIS makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 5,407 | 567 | 1,406 | 105 |
| 30 Sep 23 | 5,228 | 550 | 1,352 | 104 |
| 30 Jun 23 | 5,086 | 119 | 1,306 | 102 |
| 31 Mar 23 | 4,958 | 107 | 1,275 | 102 |
| 31 Dec 22 | 4,784 | -28 | 1,360 | 101 |
| 30 Sep 22 | 4,777 | -8 | 1,361 | 101 |
| 30 Jun 22 | 4,773 | 377 | 1,369 | 95 |
| 31 Mar 22 | 4,585 | 244 | 1,297 | 88 |
| 31 Dec 21 | 4,248 | 279 | 1,081 | 79 |
| 30 Sep 21 | 3,848 | 250 | 950 | 71 |
| 30 Jun 21 | 3,407 | 286 | 793 | 68 |
| 31 Mar 21 | 3,108 | 397 | 696 | 66 |
| 31 Dec 20 | 3,057 | 433 | 683 | 66 |
| 30 Sep 20 | 3,022 | 424 | 679 | 66 |
| 30 Jun 20 | 3,003 | 413 | 685 | 66 |
| 31 Mar 20 | 3,031 | 408 | 709 | 66 |
| 31 Dec 19 | 2,976 | 393 | 676 | 64 |
| 30 Sep 19 | 2,898 | 336 | 683 | 63 |
| 30 Jun 19 | 2,840 | 319 | 665 | 62 |
| 31 Mar 19 | 2,782 | 304 | 645 | 63 |
| 31 Dec 18 | 2,730 | 269 | 637 | 65 |
| 30 Sep 18 | 2,696 | 316 | 622 | 65 |
| 30 Jun 18 | 2,651 | 303 | 618 | 63 |
| 31 Mar 18 | 2,620 | 291 | 616 | 61 |
| 31 Dec 17 | 2,585 | 243 | 650 | 59 |
| 30 Sep 17 | 2,570 | 144 | 630 | 58 |
| 30 Jun 17 | 2,582 | 120 | 640 | 59 |
| 31 Mar 17 | 2,613 | 110 | 652 | 59 |
| 31 Dec 16 | 2,616 | 142 | 523 | 58 |
| 30 Sep 16 | 2,588 | 167 | 560 | 58 |
| 30 Jun 16 | 2,431 | 135 | 569 | 57 |
| 31 Mar 16 | 2,233 | 111 | 544 | 57 |
| 31 Dec 15 | 2,042 | 94 | 629 | 57 |
| 30 Sep 15 | 1,897 | 113 | 514 | 57 |
| 30 Jun 15 | 1,870 | 135 | 468 | 55 |
| 31 Mar 15 | 1,842 | 135 | 455 | 54 |
| 31 Dec 14 | 1,807 | 133 | 402 | 52 |
| 30 Sep 14 | 1,739 | 123 | 435 | 49 |
| 30 Jun 14 | 1,660 | 122 | 400 | 49 |
| 31 Mar 14 | 1,615 | 129 | 381 | 49 |
| 31 Dec 13 | 1,585 | 132 | 375 | 49 |
| 30 Sep 13 | 1,560 | 152 | 372 | 48 |
| 30 Jun 13 | 1,533 | 162 | 362 | 44 |
Quality Earnings: STE has high quality earnings.
Growing Profit Margin: STE became profitable in the past.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: STE's earnings have declined by 6.3% per year over the past 5 years.
Accelerating Growth: STE has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: STE has become profitable in the last year, making it difficult to compare its past year earnings growth to the Medical Equipment industry (3.3%).
Return on Equity
High ROE: STE's Return on Equity (8.8%) is considered low.